Shareholders Equity (Quarterly) Chart

View Shareholders Equity (Quarterly) for XAGE.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Shareholders Equity (Quarterly) Chart
Start Trial

Historical Shareholders Equity (Quarterly) Data

View and export this data back to 2021. Start Trial.
Date Value
June 30, 2026 -8.699M
March 31, 2026 -6.895M
December 31, 2025 -5.867M
September 30, 2025 -3.977M
June 30, 2025 -3.738M
March 31, 2025 -3.805M
December 31, 2024 -4.713M
September 30, 2024 -4.065M
June 30, 2024 -1.372M
March 31, 2024 -1.392M
December 31, 2023 24.75M
Date Value
September 30, 2023 20.92M
June 30, 2023 156.19M
March 31, 2023 155.87M
December 31, 2022 -6.374M
September 30, 2022 149.65M
June 30, 2022 148.81M
March 31, 2022 149.16M
December 31, 2021 149.69M
September 30, 2021 150.05M
June 30, 2021 0.0174M
March 31, 2021 0.0238M

Shareholders' Equity Definition

Represents the value of Shareholders' Equity as of the close of the report date, belonging to both Preferred and Common Equity Shareholders.

Read full definition.

Shareholders Equity (Quarterly) Range, Past 5 Years

View Shareholders Equity (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Shareholders Equity (Quarterly) Benchmarks

View Shareholders Equity (Quarterly) Benchmarks
Start Trial
Anika Therapeutics, Inc. 137.28M
Perspective Therapeutics, Inc. 323.86M
Achieve Life Sciences, Inc. -14.68M
MiMedx Group, Inc. 216.00M
ProText Mobility, Inc. 611.11M

Shareholders Equity (Quarterly) Related Metrics